Korro Bio (KRRO) Net Equity Issued and Repurchased (2018 - 2026)

Korro Bio's Net Equity Issued and Repurchased history runs 8 years deep, the most recent figure standing at $83.2 million for Q1 2026.

• Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $83.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $183.2 million (down 15.69% YoY) and the FY2023 annual result came in at $117.2 million, changed N/A from the prior year.
• Net Equity Issued and Repurchased was $83.2 million for Q1 2026 at Korro Bio, down from $100.0 million in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $117.2 million in Q4 2023 and bottomed at -$60000.0 in Q4 2022.
• A 4-year average of $37.6 million and a median of $31000.0 in 2022 frame the typical range for Net Equity Issued and Repurchased.
• Annual changes were most pronounced in 2022 — Net Equity Issued and Repurchased sank 154.55% — and 2023, when it surged 195516.67%.
• Korro Bio's Net Equity Issued and Repurchased stood at -$60000.0 in 2022, then jumped by 195516.67% to $117.2 million in 2023, then dropped by 14.71% to $100.0 million in 2024, then declined by 16.85% to $83.2 million in 2026.
• Business Quant data shows KRRO's Net Equity Issued and Repurchased at $83.2 million in Q1 2026, $100.0 million in Q4 2024, and $117.2 million in Q4 2023.